<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852267</url>
  </required_header>
  <id_info>
    <org_study_id>2007-068</org_study_id>
    <nct_id>NCT00852267</nct_id>
  </id_info>
  <brief_title>Lipoprotein Effects of Substituting Beef Protein for Carbohydrate</brief_title>
  <official_title>Lipoprotein Effects of Substituting Beef Protein for Carbohydrate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital &amp; Research Center Oakland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cattlemen's Beef Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital &amp; Research Center Oakland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether replacing dietary carbohydrate with protein,
      using beef as the primarily source of protein, will improve risk factors for cardiovascular
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to test the hypothesis that replacing dietary carbohydrate
      with protein, using beef as the primarily source of protein, will have beneficial effects on
      components of atherogenic dyslipidemia and postprandial lipoprotein response and that these
      effects will be independent of saturated fat intake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-HDL Cholesterol</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Apolipoprotein B</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>LDL-Cholesterol/HDL-Cholesterol</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Apolipoprotein B/Apolipoprotein AI</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>LDL peak diameter</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL subclass 3 (LDL3)</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL subclass 2 (HDL2)</measure>
    <time_frame>3 weeks, 8 weeks, and 13 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <condition>Cardiovascular Disease</condition>
  <condition>Atherogenic Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>High CHO, High SatFat Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low CHO, High SatFat Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low CHO, Low SatFat Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Carbohydrate, High Saturated Fat Diet</intervention_name>
    <description>50% Carbohydrate; 12% Protein; 38% Fat (15% Saturated Fat; 15% Monounsaturated Fat)</description>
    <arm_group_label>High CHO, High SatFat Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Carbohydrate, High Saturated Fat Diet</intervention_name>
    <description>31% Carbohydrate; 31% Protein; 38% Fat (15% Saturated Fat; 14% Monounsaturated Fat)</description>
    <arm_group_label>Low CHO, High SatFat Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Carbohydrate, Low Saturated Fat Diet</intervention_name>
    <description>31% Carbohydrate; 31% Protein; 38% Fat (8% Saturated Fat; 21% Monounsaturated Fat)</description>
    <arm_group_label>Low CHO, Low SatFat Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Blood pressure less than 150/90

          -  Body mass index (BMI)≥ 20 and ≤ 35 kg/m2

          -  Non-smoker

          -  Agrees not to consume alcohol during the study

          -  Agrees to abstain from taking dietary supplements during the study

          -  LDL-cholesterol and total cholesterol &lt; 95th percentile for age and sex

          -  Fasting triglycerides &lt; 500 mg/dL

          -  Fasting glucose concentration &lt; 126 mg/dL

          -  Hematocrit (HCT) ≥ 36%

          -  At least three months of a weight-stable state (± 3% of body weight)

        Exclusion Criteria:

          -  Personal history of coronary heart disease, cerebrovascular disease, peripheral
             vascular disease, diabetes, lung disease, bleeding disorder, liver or renal disease,
             HIV or of cancer (other than skin cancer) in the last five years

          -  Taking drugs known to affect lipid metabolism or insulin resistance, hormones, or the
             blood thinning agent warfarin

          -  Abnormal thyroid stimulating hormone (TSH)

          -  Strength trains with resistance weights more than four hours per week
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald M Krauss, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital &amp; Research Center Oakland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cholesterol Research Center</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2009</study_first_submitted>
  <study_first_submitted_qc>February 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2009</study_first_posted>
  <last_update_submitted>October 4, 2011</last_update_submitted>
  <last_update_submitted_qc>October 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ronald Krauss, M.D.</name_title>
    <organization>Children's Hospital &amp; Research Center Oakland</organization>
  </responsible_party>
  <keyword>cholesterol</keyword>
  <keyword>diet</keyword>
  <keyword>protein</keyword>
  <keyword>carbohydrate</keyword>
  <keyword>saturated fat</keyword>
  <keyword>LDL subclass</keyword>
  <keyword>healthy volunteers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

